Literature DB >> 16998233

Unstable diabetes in a patient receiving anti-TNF-alpha for rheumatoid arthritis.

J G Boulton, J T Bourne.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16998233     DOI: 10.1093/rheumatology/kel322

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  9 in total

Review 1.  Immune-Modulating Therapy for Rheumatologic Disease: Implications for Patients with Diabetes.

Authors:  Scott J Pilla; Amy Q Quan; Emily L Germain-Lee; David B Hellmann; Nestoras N Mathioudakis
Journal:  Curr Diab Rep       Date:  2016-10       Impact factor: 4.810

2.  Development of low blood glucose readings in nine non-diabetic patients treated with tumor necrosis factor-alpha inhibitors: a case series.

Authors:  Jadwiga B Czajkowska; Brandon Shutty; Susan Zito
Journal:  J Med Case Rep       Date:  2012-01-10

3.  Refractory rheumatoid factor positive polyarthritis in a female adolescent already suffering from type 1 diabetes mellitus and Hashimoto's thyroiditis successfully treated with etanercept.

Authors:  Alma Nunzia Olivieri; Dario Iafusco; Antonio Mellos; Angela Zanfardino; Angela Mauro; Carmela Granato; Maria Francesca Gicchino; Francesco Prisco; Laura Perrone
Journal:  Ital J Pediatr       Date:  2013-10-14       Impact factor: 2.638

4.  Safety, effectiveness, and pharmacokinetics of adalimumab in children with polyarticular juvenile idiopathic arthritis aged 2 to 4 years.

Authors:  Daniel J Kingsbury; Brigitte Bader-Meunier; Gina Patel; Vipin Arora; Jasmina Kalabic; Hartmut Kupper
Journal:  Clin Rheumatol       Date:  2014-02-02       Impact factor: 2.980

Review 5.  Psoriasis comorbidities: complications and benefits of immunobiological treatment.

Authors:  André Vicente Esteves de Carvalho; Ricardo Romiti; Cacilda da Silva Souza; Renato Soriani Paschoal; Laura de Mattos Milman; Luana Pizarro Meneghello
Journal:  An Bras Dermatol       Date:  2016 Nov-Dec       Impact factor: 1.896

6.  Blood glucose changes surrounding initiation of tumor-necrosis factor inhibitors and conventional disease-modifying anti-rheumatic drugs in veterans with rheumatoid arthritis.

Authors:  Patrick R Wood; Evan Manning; Joshua F Baker; Bryant England; Lisa Davis; Grant W Cannon; Ted R Mikuls; Liron Caplan
Journal:  World J Diabetes       Date:  2018-02-15

7.  Interleukin-6 receptor blockade or TNFα inhibition for reducing glycaemia in patients with RA and diabetes: post hoc analyses of three randomised, controlled trials.

Authors:  Mark C Genovese; Gerd R Burmester; Owen Hagino; Karthinathan Thangavelu; Melitza Iglesias-Rodriguez; Gregory St John; Miguel A González-Gay; Thomas Mandrup-Poulsen; Roy Fleischmann
Journal:  Arthritis Res Ther       Date:  2020-09-09       Impact factor: 5.156

8.  Proof-of-concept, randomized, controlled clinical trial of Bacillus-Calmette-Guerin for treatment of long-term type 1 diabetes.

Authors:  Denise L Faustman; Limei Wang; Yoshiaki Okubo; Douglas Burger; Liqin Ban; Guotong Man; Hui Zheng; David Schoenfeld; Richard Pompei; Joseph Avruch; David M Nathan
Journal:  PLoS One       Date:  2012-08-08       Impact factor: 3.240

9.  Etanercept-Induced Hypoglycemia in a Patient With Psoriatic Arthritis and Diabetes.

Authors:  Emily C Pfeifer; David R Saxon; Robert W Janson
Journal:  J Investig Med High Impact Case Rep       Date:  2017-09-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.